AGIO
AGIO
NASDAQ · Biotechnology

Agios Pharmaceuticals Inc

$32.27
+0.32 (+1.00%)
As of Aug 8, 10:08 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 12 75%
Hold 4 25%
Sell 0 0%
Price Target
Analyst Price Target -66.3% upside
Low Target $8.41
Average Target $10.87
High Target $14.57
Current Price $32.27
Current
$32.27
Target
$10.87
$8.41 $10.87 avg $14.57
Scenario Analysis
Bear Case
$8.41
-73.9%
Low target
Base Case
$10.87
-66.3%
Avg target
Bull Case
$14.57
+-54.8%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$46.00
-29.8% from high
52-Week Low
$22.24
+45.1% from low
Target vs 52W High
$10.87
-76.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.0%